PMDA — authorised 3 July 2015
- Marketing authorisation holder: Boehringer Ingelheim
- Status: approved
🇯🇵 Ofev in Japan
PMDA authorised Ofev on 3 July 2015
Marketing authorisation
Ofev in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in Japan
Frequently asked questions
Is Ofev approved in Japan?
Yes. PMDA authorised it on 3 July 2015.
Who is the marketing authorisation holder for Ofev in Japan?
Boehringer Ingelheim holds the Japanese marketing authorisation.